(Q40331314)

19 September 2017

title

Desferrioxamine B: reversible side effects of high daily doses (English)

1 reference

19 September 2017

Desferrioxamine B: Reversible side effects of high daily doses (English)

1 reference

25 January 2023

1 reference

G Cartei

1

1 reference

19 September 2017

T Barbui

2

1 reference

19 September 2017

M Cazzavillan

3

1 reference

19 September 2017

T Chisesi

4

1 reference

19 September 2017

E Dini

5

1 reference

19 September 2017

G. Cartei

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A238690

25 January 2023

T. Barbui

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A238690

25 January 2023

M. Cazzavillan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A238690

25 January 2023

T. Chisesi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A238690

25 January 2023

E. Dini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A238690

25 January 2023

language of work or name

English

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=238690

25 January 2023

publication date

1 July 1975

1 reference

19 September 2017

July 1975

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=238690

full work available at URL

25 January 2023

http://link.springer.com/content/pdf/10.1007/BF01635436.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF01635436/fulltext.html

25 January 2023

1 reference

http://link.springer.com/content/pdf/10.1007/BF01635436

25 January 2023

1 reference

25 January 2023

1 reference

19 September 2017

31

1

11–6

July 1975

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=238690

25 January 2023

volume

31

1 reference

19 September 2017

issue

1

1 reference

19 September 2017

page(s)

11-16

1 reference

A comparison of desferrioxamine-induced sideruria and measurement of labile iron store as indices of body iron status

19 September 2017

cites work

1 reference

12 December 2020

[Urinary iron after desferrioxamine. I. Effectiveness and tolerance of high doses of the drug]

1 reference

12 December 2020

[Liver parenchyma damage by treatment with desferrioxamine B]

1 reference

12 December 2020

EXcretion and distribution of iron during chronic deferoxamine therapy

1 reference

12 December 2020

Desferal therapy in iron storage disease

1 reference

12 December 2020

Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical Progress

1 reference

12 December 2020

CHELATING AGENTS IN THE DIAGNOSIS AND TREATMENT OF IRON OVERLOAD IN THALASSEMIA

1 reference

12 December 2020

Damage to the liver parenchyma induced by desferrioxamine B therapy

1 reference

12 December 2020

2

58

605

G. Cartei

1973

1 reference

25 January 2023

Identifiers

DOI

10.1007/BF01635436

2 references

19 September 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=238690

25 January 2023

2 references

19 September 2017